Development of different xenograft mouse models of clear cell renal cell carcinoma, and analysis of the efficacy ofangiotensin-II type 1 receptor antagonists combined with sunitinib.
G. Verhoest(Centre National de la Recherche Scientifique)
theses.fr (ABES)
June 16, 2014
Cited by 0
Related Papers
Sunitinib Combined with Angiotensin-2 Type-1 Receptor Antagonists Induces More Necrosis: A Murine Xenograft Model of Renal Cell Carcinoma
|BioMed Research International|2014|260